Processing, please wait...

Dr Thibaud MATHIS


Thibaud MATHIS's publications (41)

Long-term follow-up of diabetic macular edema treated with dexamethasone implant: a real-life study.

Dec, 2020

To evaluate the efficacy and safety of intravitreal dexamethasone implant (DEX-implant) for diabetic macular edema (DME) in real-life practice with an extended follow-up for up to 5 year. read more

Acta diabetologica

Current role of intravitreal injections in Irvine Gass syndrome-CRIIG study.

Nov, 2020

To analyze the role of intravitreal anti-vascular endothelial growth factor (anti-VEGF) or steroid injection for the management of Irvine Gass syndrome. read more

International ophthalmology

Persistent Placoid Maculopathy: Prognosis Factors and Functional Outcomes.

Oct, 2020

: To identify prognosis factors and functional outcomes of persistent placoid maculopathy (PPM). : We collected personal PPM cases and combined them with the data from the literature. : 68 eyes of 37 patients with PPM were analyzed, including six new cases. Twenty-six patients were men (70%) with a mean age of 51.8 years old. The mean initial visual acuity (VA) was 0.52 LogMar ± 0.55 for a mean final VA of 0.49 LogMar ± 0.51. Risk factors for poor VA included: initial VA less than 0.2 LogMar ( < .0001), cardiovascular risk factor ( = .008), autoimmune-related and/or systemic pro-inflammatory conditions ( = .003), choroidal neovascularization ( = .001), macular atrophy ( = .03) and absence of systemic corticosteroid treatment ( = .03). : PPM is a choroidal inflammation. Identifying prognosis factors may help to guide treatment and follow-up. We showed that anti-inflammatory drugs, and anti-VEGF injections in cases of choroidal neovascularization, may lead to better outcomes. read more

Ocular immunology and inflammation
Load more  

Thibaud MATHIS's main interests